126 related articles for article (PubMed ID: 11344492)
1. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
Rudnick E; Khakoo Y; Antunes NL; Seeger RC; Brodeur GM; Shimada H; Gerbing RB; Stram DO; Matthay KK
Med Pediatr Oncol; 2001 Jun; 36(6):612-22. PubMed ID: 11344492
[TBL] [Abstract][Full Text] [Related]
2. Clinical Presentation, Management, and Diagnostic Performance of 2021 Criteria for Paraneoplastic Neurologic Syndromes in Childhood.
Zhou J; Jin M; Su Y; Zhuo X; Fu L; Ren X; Ren C; Zhou A; Li J; Zhang W
Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200242. PubMed ID: 38657195
[TBL] [Abstract][Full Text] [Related]
3. Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
Kumar P; Willard VW; Embry L; Naranjo A; LaBarre B; Matthay KK; de Alarcon PA
Pediatr Blood Cancer; 2024 Jul; 71(7):e31039. PubMed ID: 38689540
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective.
Rossor T; Yeh EA; Khakoo Y; Angelini P; Hemingway C; Irani SR; Schleiermacher G; Santosh P; Lotze T; Dale RC; Deiva K; Hero B; Klein A; de Alarcon P; Gorman MP; Mitchell WG; Lim M;
Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35260471
[TBL] [Abstract][Full Text] [Related]
5. Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma.
Rosenberg MI; Greenstein E; Buchkovich M; Peres A; Santoni-Rugiu E; Yang L; Mikl M; Vaksman Z; Gibbs DL; Reshef D; Salovin A; Irwin MS; Naranjo A; Ulitsky I; de Alarcon PA; Matthay KK; Weigman V; Yaari G; Panzer JA; Friedman N; Maris JM
Cell Rep; 2023 Aug; 42(8):112879. PubMed ID: 37537844
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological and some clinical characteristics of neuroblastoma in Mexican children (1996-2005).
Juárez-Ocaña S; Palma-Padilla V; González-Miranda G; Siordia-Reyes AG; López-Aguilar E; Aguilar-Martínez M; Mejía-Aranguré JM; Carreón-Cruz R; Rendón-Macías ME; Fajardo-Gutiérrez A
BMC Cancer; 2009 Aug; 9():266. PubMed ID: 19650918
[TBL] [Abstract][Full Text] [Related]
7. Assessing Long-Term Neurologic Outcomes in SAMD9L-Related Ataxia-Pancytopenia Syndrome.
Zingariello CD; Chen DH; Raskind WH; Slayton WB; Subramony S; Severance J; Feagle M; Rasmussen SA
Mov Disord Clin Pract; 2024 Jun; 11(6):728-733. PubMed ID: 38594844
[TBL] [Abstract][Full Text] [Related]
8. Update on diagnosis, treatment, and prognosis in opsoclonus-myoclonus-ataxia syndrome.
Gorman MP
Curr Opin Pediatr; 2010 Dec; 22(6):745-50. PubMed ID: 20871403
[TBL] [Abstract][Full Text] [Related]
9. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.
Cooper R; Khakoo Y; Matthay KK; Lukens JN; Seeger RC; Stram DO; Gerbing RB; Nakagawa A; Shimada H
Med Pediatr Oncol; 2001 Jun; 36(6):623-9. PubMed ID: 11344493
[TBL] [Abstract][Full Text] [Related]
10. Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004.
Matthay KK; Blaes F; Hero B; Plantaz D; De Alarcon P; Mitchell WG; Pike M; Pistoia V
Cancer Lett; 2005 Oct; 228(1-2):275-82. PubMed ID: 15922508
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma and opsoclonus-myoclonus-ataxia syndrome--clinical and pathological characteristics.
Stefanowicz J; Izycka-Swieszewska E; Drozyńska E; Pienczk J; Połczyńska K; Czauderna P; Sierota D; Bień E; Stachowicz-Stencel T; Kosiak W; Balcerska A
Folia Neuropathol; 2008; 46(3):176-85. PubMed ID: 18825593
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma.
Koh PS; Raffensperger JG; Berry S; Larsen MB; Johnstone HS; Chou P; Luck SR; Hammer M; Cohn SL
J Pediatr; 1994 Nov; 125(5 Pt 1):712-6. PubMed ID: 7525913
[TBL] [Abstract][Full Text] [Related]
13. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae.
Mitchell WG; Davalos-Gonzalez Y; Brumm VL; Aller SK; Burger E; Turkel SB; Borchert MS; Hollar S; Padilla S
Pediatrics; 2002 Jan; 109(1):86-98. PubMed ID: 11773546
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial.
de Alarcon PA; Matthay KK; London WB; Naranjo A; Tenney SC; Panzer JA; Hogarty MD; Park JR; Maris JM; Cohn SL
Lancet Child Adolesc Health; 2018 Jan; 2(1):25-34. PubMed ID: 29376112
[TBL] [Abstract][Full Text] [Related]
15. Acute cerebellar ataxia, acute cerebellitis, and opsoclonus-myoclonus syndrome.
Desai J; Mitchell WG
J Child Neurol; 2012 Nov; 27(11):1482-8. PubMed ID: 22805251
[TBL] [Abstract][Full Text] [Related]
16. Opsoclonus-myoclonus-ataxia syndrome in children.
Bhatia P; Heim J; Cornejo P; Kane L; Santiago J; Kruer MC
J Neurol; 2022 Feb; 269(2):750-757. PubMed ID: 33779841
[TBL] [Abstract][Full Text] [Related]
17. Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.
Schleiermacher G; Mosseri V; London WB; Maris JM; Brodeur GM; Attiyeh E; Haber M; Khan J; Nakagawara A; Speleman F; Noguera R; Tonini GP; Fischer M; Ambros I; Monclair T; Matthay KK; Ambros P; Cohn SL; Pearson AD
Br J Cancer; 2012 Oct; 107(8):1418-22. PubMed ID: 22976801
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study.
Nuchtern JG; London WB; Barnewolt CE; Naranjo A; McGrady PW; Geiger JD; Diller L; Schmidt ML; Maris JM; Cohn SL; Shamberger RC
Ann Surg; 2012 Oct; 256(4):573-80. PubMed ID: 22964741
[TBL] [Abstract][Full Text] [Related]
19. Mycoplasma pneumoniae associated opsoclonus-myoclonus syndrome in three cases.
Huber BM; Strozzi S; Steinlin M; Aebi C; Fluri S
Eur J Pediatr; 2010 Apr; 169(4):441-5. PubMed ID: 19774394
[TBL] [Abstract][Full Text] [Related]
20. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group.
Russo C; Cohn SL; Petruzzi MJ; de Alarcon PA
Med Pediatr Oncol; 1997 Apr; 28(4):284-8. PubMed ID: 9078325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
